Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000818640 | SCV000959264 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2021-03-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). This variant has not been reported in the literature in individuals with DCTN1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with leucine at codon 1182 of the DCTN1 protein (p.Ser1182Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. |
Clinical Genetics, |
RCV001700309 | SCV001917824 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700309 | SCV001954346 | uncertain significance | not provided | no assertion criteria provided | clinical testing |